Literature DB >> 9006347

Tissue inhibitor of metalloproteinases-3 is a component of Bruch's membrane of the eye.

R N Fariss1, S S Apte, B R Olsen, K Iwata, A H Milam.   

Abstract

Mutations in tissue inhibitor of metalloproteinases (TIMP)-3 are found in some patients with Sorsby's fundus dystrophy, a retinal degeneration characterized by abnormal deposits in Bruch's membrane and choroidal neovascularization. The purpose of this study was to localize TIMP-3 in the retina/choroid of normal human and animal eyes. Immunolabeling was performed on unfixed and fixed sections of human eyes aged 24 to 85 years and unfixed sections of baboon, chicken, cow, pig, and rat eyes using a monoclonal antibody against a human TIMP-3 synthetic peptide. The antibody produced strong immunolabeling of Bruch's membrane and drusen and weak labeling of retina blood vessels in unfixed human and baboon eyes. Unfixed chicken, cow, pig, and rat tissues showed no reactivity. After antigen retrieval, all fixed human eyes showed specific labeling of Bruch's membrane and drusen, which was strongest in eyes from elderly donors. The results indicate that TIMP-3 is an extracellular matrix component of Bruch's membrane. Thus, abnormal local function of TIMP-3 may lead to the characteristic Bruch's membrane deposits and choroidal neovascularization found in Sorsby's fundus dystrophy. Specific labeling of drusen raises the possibility that altered TIMP-3-mediated matrix remodeling may contribute to age-related degenerative changes in Bruch's membrane.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9006347      PMCID: PMC1858531     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  23 in total

1.  Identification of glycosaminoglycans in age-related macular deposits.

Authors:  M Kliffen; C M Mooy; T M Luider; J G Huijmans; S Kerkvliet; P T de Jong
Journal:  Arch Ophthalmol       Date:  1996-08

2.  Sorsby's fundus dystrophy. A South African family with a point mutation on the tissue inhibitor of metalloproteinases-3 gene on chromosome 22.

Authors:  A L Peters; J Greenberg
Journal:  Retina       Date:  1995       Impact factor: 4.256

3.  Vitamin A megatherapy for retinal abnormalities.

Authors:  T S Acott; R G Weleber
Journal:  Nat Med       Date:  1995-09       Impact factor: 53.440

4.  Localization of TIMP-3 mRNA expression to the retinal pigment epithelium.

Authors:  N G Della; P A Campochiaro; D J Zack
Journal:  Invest Ophthalmol Vis Sci       Date:  1996-08       Impact factor: 4.799

5.  TIMP-3 is expressed in the human retinal pigment epithelium.

Authors:  A Ruiz; P Brett; D Bok
Journal:  Biochem Biophys Res Commun       Date:  1996-09-13       Impact factor: 3.575

6.  Night blindness in Sorsby's fundus dystrophy reversed by vitamin A.

Authors:  S G Jacobson; A V Cideciyan; G Regunath; F J Rodriguez; K Vandenburgh; V C Sheffield; E M Stone
Journal:  Nat Genet       Date:  1995-09       Impact factor: 38.330

7.  Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy.

Authors:  B H Weber; G Vogt; R C Pruett; H Stöhr; U Felbor
Journal:  Nat Genet       Date:  1994-12       Impact factor: 38.330

8.  Identification and characterization of human tissue inhibitor of metalloproteinase-3 and detection of three additional metalloproteinase inhibitor activities in extracellular matrix.

Authors:  N S Kishnani; P W Staskus; T T Yang; F R Masiarz; S P Hawkes
Journal:  Matrix Biol       Date:  1995-02       Impact factor: 11.583

9.  Sorsby fundus dystrophy. A family with the Ser181Cys mutation of the tissue inhibitor of metalloproteinases 3.

Authors:  R D Carrero-Valenzuela; M L Klein; R G Weleber; W H Murphey; M Litt
Journal:  Arch Ophthalmol       Date:  1996-06

10.  Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2).

Authors:  T Hayakawa; K Yamashita; E Ohuchi; A Shinagawa
Journal:  J Cell Sci       Date:  1994-09       Impact factor: 5.285

View more
  35 in total

Review 1.  Matrix metalloproteinase biology applied to vitreoretinal disorders.

Authors:  C S Sethi; T A Bailey; P J Luthert; N H Chong
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

2.  Expression and distribution of matrix metalloproteinases and their inhibitors in the human iris and ciliary body.

Authors:  J Lan; R K Kumar; N Di Girolamo; P McCluskey; D Wakefield
Journal:  Br J Ophthalmol       Date:  2003-02       Impact factor: 4.638

3.  A novel TIMP3 mutation associated with a retinitis pigmentosa-like phenotype.

Authors:  Meghan J DeBenedictis; Yosef Gindzin; Enrico Glaab; Bela Anand-Apte
Journal:  Ophthalmic Genet       Date:  2020-07-27       Impact factor: 1.803

4.  Adenovirus mediated gene delivery of tissue inhibitor of metalloproteinases-3 induces death in retinal pigment epithelial cells.

Authors:  Mohammed A Majid; Valerie A Smith; David L Easty; Andrew H Baker; Andrew C Newby
Journal:  Br J Ophthalmol       Date:  2002-01       Impact factor: 4.638

5.  Association of variants in the LIPC and ABCA1 genes with intermediate and large drusen and advanced age-related macular degeneration.

Authors:  Yi Yu; Robyn Reynolds; Jesen Fagerness; Bernard Rosner; Mark J Daly; Johanna M Seddon
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-28       Impact factor: 4.799

6.  Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis.

Authors:  A H Baker; A B Zaltsman; S J George; A C Newby
Journal:  J Clin Invest       Date:  1998-03-15       Impact factor: 14.808

Review 7.  Metalloproteinases as mediators of inflammation and the eyes: molecular genetic underpinnings governing ocular pathophysiology.

Authors:  Mahavir Singh; Suresh C Tyagi
Journal:  Int J Ophthalmol       Date:  2017-08-18       Impact factor: 1.779

Review 8.  Age-related macular degeneration: genetics and biology coming together.

Authors:  Lars G Fritsche; Robert N Fariss; Dwight Stambolian; Gonçalo R Abecasis; Christine A Curcio; Anand Swaroop
Journal:  Annu Rev Genomics Hum Genet       Date:  2014-04-16       Impact factor: 8.929

9.  Tissue inhibitor of matrix metalloproteinase-3 levels in the extracellular matrix of lung, kidney, and eye increase with age.

Authors:  Anne M Macgregor; Charles G Eberhart; Mostafa Fraig; Jie Lu; Marc K Halushka
Journal:  J Histochem Cytochem       Date:  2008-10-27       Impact factor: 2.479

10.  Influence of TIMP3/SYN3 polymorphisms on the phenotypic presentation of age-related macular degeneration.

Authors:  Daniel Ardeljan; Catherine B Meyerle; Elvira Agron; Jie Jin Wang; Paul Mitchell; Emily Y Chew; Jing Zhao; Arvydas Maminishkis; Chi-Chao Chan; Jingsheng Tuo
Journal:  Eur J Hum Genet       Date:  2013-02-20       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.